Respiratory syncytial virus (RSV) programme: information for healthcare professionals
This guidance is for health practitioners implementing the vaccination programme to protect pregnant women and older adults from RSV.
Documents
Details
The aim of the respiratory syncytial virus (RSV) vaccination programme is to reduce the incidence and severity of RSV disease, and hospitalisation as a result of RSV disease in infants and eligible older adults.
All adults turning 75 years of age on or after 1 September 2024 (born on or after 1 September 1949) should be offered RSV vaccination on or shortly after their 75th birthday.
All pregnant women should be offered the RSV vaccination from week 28 of their pregnancy.
These are year-round, ongoing programmes.
Training on the guidance is available: